AzTrials
AzTrials

HeadacheNCT03166358

Yoga for Pediatric Tension-Type Headache

A study testing Hatha yoga in people with Headache, run by Matthew Morris at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study will determine the efficacy of an 8-week Hatha yoga intervention for adolescents with tension-type headache (TTH) and will assess theoretically-driven mediators of treatment response, including experimental pain sensitivity, chronic stress, and negative cognitions linked to chronic pain. Read more about this study

Who is it for?
Ages 13 to 18 years
Conditions the study is for
Headache
What is being tested?
Hatha yoga
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteUnited States
Study dates
1 Sep 2015to 1 Aug 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Eligible participants will have a diagnosis of TTH with or without migraines according to the International Classification for Headache Disorders criteria, be between 13 and 18 years old (inclusive), English-speaking, and willing to be randomized and attend yoga sessions regularly.

Who cannot join

  • Participants will be excluded if they have any injury, disease, or metabolic dysfunction known to influence pain, have any physical limitations deemed by a medical practitioner to preclude yoga practice, had attended yoga classes in the previous 3 months, are currently pregnant, or have a history of drug or alcohol dependence within 6 months of screening.

Trial locations and contacts

1 site in 1 country.

Matthew C Morris, PhD contact

6153276962

mmorris@mmc.edu

United States1 site, 1 recruiting
  • Meharry Medical College

    Nashville, Tennessee, 37208

    Matthew C Morris, PhD, 615-327-6962, mmorris@mmc.edu

    Recruiting

Other trials in United States

About this study

This study will determine the efficacy of an 8-week Hatha yoga intervention for adolescents with tension-type headache (TTH) and will assess theoretically-driven mediators of treatment response, including experimental pain sensitivity, chronic stress, and negative cognitions linked to chronic pain.

Read the detailed description

Adolescents (ages 13 to 18) with TTH will be randomly assigned to either a Hatha yoga intervention (n = 20) or a wait-list control condition (n = 20). The yoga intervention will consist of 8 weekly classes lasting one hour each taught by an experienced yoga teacher. Each class will have a maximum of 10 participants. A baseline assessment including an experimental pain protocol, questionnaires, and hair samples (to determine cortisol concentrations in the past month) will be completed prior to the intervention. Biweekly questionnaires will be completed by both intervention and wait-list groups during the 8-week intervention period. The post-intervention assessment will include the experimental pain protocol, questionnaires, and hair samples (to determine cortisol concentrations in the past month). The wait-list control group will subsequently receive the yoga intervention and complete post-intervention and follow-up assessments (i.e., the wait-list group will complete one more experimental pain protocol and will provide one more hair sample than the intervention group); these data will then be merged with that of the yoga group to examine pre- and post-intervention effects. Both intervention and wait-list groups will complete questionnaires 3 months following completion of the yoga protocol.

Specific Aim 1: To determine the safety, feasibility, and acceptability of an 8-week Hatha Yoga Protocol (HYP) in adolescents (ages 13 to 18) with tension-type headache (CTTH). Hypothesis: At least 80% of adolescents will complete the HYP. Attrition rates will be compared between HYP and control groups to determine whether results may be biased given different durations of the study protocols between the two groups and interval between recruitment and intervention (i.e., control group will be in the protocol for two additional months and the intervention will be delayed by 8 weeks).

Specific Aim 2: To evaluate changes in primary outcomes (frequency and intensity of headaches, pain-related functional disability, health-related quality of life, medication use) from baseline to post-intervention in the HYP and usual care wait-list controls. Hypothesis: Participants in the HYP group will demonstrate greater reduction in headache frequency and intensity, decreases in pain-related functional disability, improvement in health-related quality of life, and reduction in medication use compared to wait-list controls from baseline to post-intervention. Secondary analyses will examine changes from pre- to post-intervention for the entire sample once the waitlist group has completed the HYP; in addition, sustained intervention effects will be determined by examining changes from post-intervention to 3-month follow-up for the entire sample.

Specific Aim 3: To assess changes in potential mediators of clinical outcomes following the HYP, including responses to experimental pain [conditioned pain modulation (CPM), temporal summation to second pain (TSSP)], alterations in stress response systems [hair cortisol concentrations, self-reported stress levels, stress hormone responses to experimental pain (cortisol, alpha-amylase, DHEA), heart rate variability responses to experimental pain] and pain-related cognitions (catastrophizing, self-efficacy, acceptance). Hypothesis: Participants in the HYP group will show increased CPM, decreased TSSP, reduced hair cortisol concentrations and self-reported stress levels, lower cortisol and alpha-amylase responses to experimental pain, higher DHEA responses to experimental pain, lower heart rate variability prior to experimental pain, reduced pain catastrophizing, increased pain self-efficacy, and increased pain acceptance compared to wait-list controls at post-intervention.

Although yoga has shown promise as a complementary health approach for chronic pain in adults, few studies have examined the potential efficacy of yoga for adolescents with chronic pain. Anticipated findings from the proposed study will help to determine whether - and how - an 8-week yoga intervention can improve pain-related outcomes in adolescents with TTH; these findings will be critical for refinement of the HYP for youth with TTH and for the design and implementation of a larger-scale, randomized controlled trial with an active control condition.

Background and Significance

TTH is common in youth and associated with significant functional disability. Complementary health approaches such as Hatha yoga, which emphasize physical postures, breathing exercises, and meditation, have been shown to reduce chronic pain-related disability. The only known pilot study of yoga for youth with headache showed moderate but non-significant improvement in daily functioning from baseline to post-intervention (Hainsworth et al., 2014). A randomized controlled trial of yoga for headache pain in adults found that the yoga group exhibited reduced migraine frequency and intensity, lower pain severity, and less medication use for headache compared to the control group after 12 weeks. Potential mechanisms underlying improvements in pain outcomes following yoga interventions include physiological, behavioral and psychological changes. Adults with TTH are characterized by impaired CPM and enhanced TSSP. Moreover, increased pain sensitivity in adults with TTH appears to be exacerbated by chronic stress, sustained physiological arousal, and negative cognitions. The proposed study addresses a critical gap in the literature by investigating the safety, feasibility, and efficacy of Hatha yoga as a complementary treatment approach for youth with TTH.

Preliminary Studies

Members of this research team have previously employed a similar experimental pain protocol to demonstrate elevated TSSP in female adolescents with functional abdominal pain, elevated TSSP in adolescents with both functional abdominal pain and a history of physical or sexual assault/abuse, and racial differences in both TSSP and CPM in healthy youth ages 10 to 17.

Sample Size Justification and Statistical Analysis Plan

Sample size estimation: Prior yoga interventions in youth with chronic pain suggest medium-to-large effect sizes (Cohen's d comparing mean changes from baseline to post-intervention) for indices of changes in pain-related functional disability. For power calculations, G*Power 3.1.9.2 was used to estimate the sample size required for estimated effect sizes ranging from .50 to .80. Assuming a Type I error rate of α = .05 and statistical power of 0.80, results indicated a range from 16 to 34 total participants. Assuming a 20% attrition rate and adopting the more conservative anticipated total n = 34, the investigators estimate that 40 total subjects will need to be recruited (20 per group).

Data analytic strategy: Group differences in primary outcomes (Specific Aim 2) will be tested using analysis of covariance, controlling for baseline scores on these outcome variables. An intent-to-treat analysis of primary outcome measures (including all enrolled participants and utilizing the last observation carry forward approach) will be conducted to confirm findings in participants who complete the HYP.

A series of linear regressions will test the direct effects of the intervention on outcome variables and the indirect effects of mediators on the relationship between mediator and outcome (Specific Aim 3). Mediation analyses will be run using the Preacher and Hayes (2008) SPSS Macro for Multiple Mediation. In order for statistical mediation to occur, two criteria are necessary: 1) there is an effect to be mediated (i.e., a significant association between intervention and the outcome), and 2) the indirect effect of intervention on outcome via mediator was significant. The indirect effect will be considered significant at the p < .05 level if the corresponding bootstrapped confidence interval does not contain zero. Bootstrapping procedures will test each mediation model by generating a 95% confidence interval (bias corrected) around the indirect effect test statistic in a series of 1000 Bootstrap samples repeatedly drawn from the full sample.

Potential limitations. The pilot study sample size is modest but will yield critical data regarding effect sizes for primary pain-related outcome variables as well as potential mediators of treatment effects.

Conditions
Headache
Being tested
Hatha yoga
Medical subject headings
Headache

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hatha yogaBehavioural

    8 Hatha yoga classes lasting approximately one hour each and delivered in small group format (i.e., classes no larger than 8 participants). Classes are tailored to address pediatric tension-type headache.

Study groups in NCT03166358
Study groupRoleWhat they receive
hatha yoga interventionExperimentalParticipants randomized to the intervention are asked to attend 8 hatha yoga classes delivered in a group format.
Receives: Behavioral: Hatha yoga
waitlist controlNo interventionParticipants randomized to the waitlist control condition complete assessments while the intervention group completes the yoga intervention. They are given the option to complete 8 hatha yoga classes delivered in group format once the waitlist period is finished.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Headache diary - changes in headache frequency over follow-up

    Headache frequency

    Measured: baseline, 2-week, 4-week, 6-week, post-intervention, 3-month follow-up

  2. Headache diary - changes in headache intensity over follow-up

    Headache intensity

    Measured: baseline, 2-week, 4-week, 6-week, post-intervention, 3-month follow-up

  3. Functional Disability Inventory - changes in pain-related functional disability over follow-up

    pain-related functional disability: perceived impact of general and physical health on psychosocial functioning in the last 2 weeks

    Measured: baseline, 2-week, 4-week, 6-week, post-intervention, 3-month follow-up

  4. Health-Related Quality of Life- Short Form-36: changes in physical functioning over follow-up

    health-related quality of life: physical functioning subscale

    Measured: baseline, 2-week, 4-week, 6-week, post-intervention, 3-month follow-up

  5. Headache Diary - changes in medication use over follow-up

    frequency/type of medication used for preventive or abortive purposes

    Measured: baseline, 2-week, 4-week, 6-week, post-intervention, 3-month follow-up

Secondary outcomes (6)
  1. changes in temporal summation from pre-intervention to immediately following intervention (8 weeks)

    temporal summation to second pain assessed with a TSA-II Neurosensory Analyzer

    Measured: baseline, post-intervention (8 weeks) [waitlist group will complete an optional third assessment after they finish the yoga classes)

  2. changes in conditioned pain modulation from pre-intervention to immediately following intervention (8 weeks)

    conditioned pain modulation assessed with a TSA-II Neurosensory Analyzer and hot water bath

    Measured: baseline, post-intervention (8 weeks) [waitlist group will complete an optional third assessment after they finish the yoga classes)

  3. hair cortisol concentrations - changes in hair cortisol levels from pre-intervention to immediately following intervention (8 weeks)

    hair cortisol levels in the previous month will be determined using 1-cm hair samples

    Measured: baseline, post-intervention (8 weeks) [waitlist group will complete an optional third assessment after they finish the yoga classes)

  4. changes in cortisol reactivity to experimental pain task from pre-intervention to immediately following intervention (8 weeks)

    salivary cortisol will be determined using 5 saliva samples collected during each experimental pain session

    Measured: baseline, post-intervention (8 weeks) [waitlist group will complete an optional third assessment after they finish the yoga classes)

  5. changes in alpha-amylase reactivity to experimental pain task from pre-intervention to immediately following intervention (8 weeks)

    salivary alpha-amylase will be determined using 5 saliva samples collected during each experimental pain session

    Measured: baseline, post-intervention (8 weeks) [waitlist group will complete an optional third assessment after they finish the yoga classes)

  6. changes in DHEA reactivity to experimental pain task from pre-intervention to immediately following intervention (8 weeks)

    salivary DHEA will be determined using 5 saliva samples collected during each experimental pain session

    Measured: baseline, post-intervention (8 weeks) [waitlist group will complete an optional third assessment after they finish the yoga classes)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 May 2017
  2. Study start1 Sep 2015
  3. Primary completion1 Aug 2018 (estimated)
  4. Study completion1 Aug 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants are randomized to either a hatha yoga intervention or a waitlist control condition.
Masking
Single blind
Who is masked
Care provider
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03166358
Sponsor's protocol ID
15-07-410
Status last verified
May 2017
First submitted
22 May 2017
Last updated
25 May 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be made available to other researchers.

Questions about this trial

What is this clinical trial studying?

A study testing Hatha yoga in people with Headache, run by Matthew Morris at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 May 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Matthew C Morris, PhD (6153276962, mmorris@mmc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Headache diary - changes in headache frequency over follow-up (time frame: baseline, 2-week, 4-week, 6-week, post-intervention, 3-month follow-up). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 May 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in